Tekla Life Sciences Investors (HQL) Insider Trading
Total insider buys:
- $4,526,361.72
Total insider sells:
- $0.00
Most recent insider trade:
- May 6, 2024
Most active insider trader:
- Saba Capital Management, L.P.
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 6, 2024 | Major Shareholder | 10,713 | $13.62 | Buy | $145,911.06 | |
| May 2, 2024 | Major Shareholder | 26,274 | $13.46 | Buy | $353,648.04 | |
| April 30, 2024 | Major Shareholder | 16,573 | $13.13 | Buy | $217,603.49 | |
| April 26, 2024 | Major Shareholder | 120,304 | $13.00 | Buy | $1,563,952.00 | |
| April 24, 2024 | Major Shareholder | 20,529 | $13.12 | Buy | $269,340.48 | |
| April 22, 2024 | Major Shareholder | 2,022 | $12.88 | Buy | $26,043.36 | |
| April 18, 2024 | Major Shareholder | 81,738 | $12.80 | Buy | $1,046,246.40 | |
| April 9, 2024 | Director | 400 | $13.32 | Buy | $5,328.00 | |
| Jan. 2, 2024 | Director | 1,000 | $13.80 | Buy | $13,800.00 | |
| Sept. 25, 2023 | President | 10,096 | $12.39 | Buy | $125,089.44 | |
| Sept. 20, 2023 | President | 12,000 | $12.68 | Buy | $152,160.00 | |
| March 23, 2022 | Director | 92 | $16.27 | Buy | $1,496.84 | |
| Jan. 26, 2022 | Director | 593 | $17.54 | Buy | $10,401.22 | |
| Aug. 11, 2021 | President | 6,403 | $21.63 | Buy | $138,496.89 | |
| Oct. 26, 2020 | President | 6,175 | $17.52 | Buy | $108,186.00 | |
| Oct. 21, 2020 | President | 5,950 | $17.75 | Buy | $105,612.50 | |
| May 21, 2020 | President | 5,950 | $17.74 | Buy | $105,553.00 | |
| March 17, 2020 | President | 8,300 | $13.27 | Buy | $110,141.00 | |
| Jan. 25, 2018 | Director | 1,300 | $21.04 | Buy | $27,352.00 |
First«1 of 1»Last
Insiders are buying Tekla Life Sciences Investors stock.
The insider traders at Tekla Life Sciences Investors are: Saba Capital Management, L.P., Daniel R Omstead, Kathleen Goetz, Daniel R. Omstead, Thomas M Kent, and Todd Reit
The most active insider trader at Tekla Life Sciences Investors is Saba Capital Management, L.P. with 7 trades.
Saba Capital Management, L.P. has bought the most Tekla Life Sciences Investors stock with a total value of $3,768,655.89.
The most recent insider trade for Tekla Life Sciences Investors was on May 6, 2024.
The single biggest insider buy for Tekla Life Sciences Investors was from Saba Capital Management, L.P. with a total value of $1,563,952.00 on April 26, 2024.